Capillary zone electrophoresis and capillary electrophoresis-mass spectrometry for analyzing qualitative and quantitative variations in therapeutic albumin

Analytica Chimica Acta

Volumn 800, Issue , 2013, Pages 103-110

  Marie, Anne Lise ^a,b   Przybylski, Cédric ^c   Gonnet, Florence ^c   Daniel, Régis ^c   Urbain, Rémi ^d   Chevreux, Guillaume ^d   Jorieux, Sylvie ^d   Taverna, Myriam ^a,b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b UNIV PARIS SUD   (France)

^c UNIVERSITÉ D EVRY VAL D ESSONNE   (France)

^d LFB   (France)

Author keywords

Advanced Glycation End products; Capillary zone electrophoresis; Human serum albumin; Mass spectrometry

Indexed keywords

ADVANCED GLYCATION END PRODUCTS; CAPILLARY COATINGS; CAPILLARY ELECTROPHORESIS-MASS SPECTROMETRIES; CAPILLARY ZONE ELECTROPHORESIS; CARBOXYPEPTIDASE A; HUMAN SERUM ALBUMINS; LIQUID INTERFACE; PHARMACEUTICAL INDUSTRY;

COMMERCE; MASS SPECTROMETRY; SEPARATION;

CAPILLARY ELECTROPHORESIS;

ADVANCED GLYCATION END PRODUCT; BUFFER; CARBOXYPEPTIDASE A; HUMAN SERUM ALBUMIN;

ARTICLE; BINDING AFFINITY; CAPILLARY ZONE ELECTROPHORESIS; CONTROLLED STUDY; GLYCATION; MASS SPECTROMETRY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REACTION ANALYSIS; SEPARATION TECHNIQUE;

N(Δ)-(4-CARBOXY-4,6-DIMETHYL-5,6-DIHYDROXY-1,4,5,6-TETRAHYDROPYRIMIDIN-2-YL)-ORNITHINE; N(Δ)-[5-(2,3,4-TRIHYDROXYBUTYL)-5-HYDRO-4-IMIDAZOLON-2-YL]-ORNITHINE; 3-DEOXYGLUCOSONE-DERIVED LYSINE DIMER 1,3-DI(N(E)-LYSINO)-4-(2,3,4-TRIHYDROXYBUTYL)-IMIDAZOLIUM SALT; 4-(2-HYDROXYETHYL)-1-PIPERAZINE-ETHANE-SULFONIC ACID; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCTS; AGE; BACKGROUND ELECTROLYTE; BGE; CAPILLARY ELECTROPHORESIS; CAPILLARY ELECTROPHORESIS-MASS SPECTROMETRY; CAPILLARY ZONE ELECTROPHORESIS; CARBOXYPEPTIDASE A; CE; CE-MS; CEL; CML; CPA; CYSTEINYLATED HSA; CZE; DGH; DOLD; ELECTROOSMOTIC FLOW; ELECTROSPRAY IONIZATION; EOF; ESI; GH; GLUTATHIONYLATED HSA; GLYOXAL-DERIVED LYSINE DIMER, 1,3-DI(N(E)-LYSINO)-IMIDAZOLIUM SALT; GOLD; HEPES; HOMOCYSTEINYLATED HSA; HPC; HSA; HSA MINUS ASPARTIC ACID AND ALANINE FROM THE N-TERMINUS; HSA MINUS LEUCINE FROM THE C-TERMINUS; HSA+CYS; HSA+G; HSA+HCYS; HSA-DA; HSA-L; HSA-SNO; HSA-SO(2)H; HSA-SO(3)H; HSA-SOH; HSA-SULFENIC ACID; HSA-SULFINIC ACID; HSA-SULFONIC ACID; HUMAN SERUM ALBUMIN; HYDROXYPROPYL CELLULOSE; ION TRAP; IT; MASS SPECTROMETRY; METHYLGLYOXAL-DERIVED LYSINE DIMER, 1,3-DI(N(E)-LYSINO)-4-METHYL-IMIDAZOLIUM SALT; MGH; MOLD; MS; N(E)-(1-CARBOXYETHYL)-LYSINE; N(E)-CARBOXYMETHYL-LYSINE; N(Δ)-(5-HYDRO-4-IMIDAZOLON-2-YL)-ORNITHINE; N(Δ)-(5-HYDRO-5-METHYL-4-IMIDAZOLON-2-YL)-ORNITHINE; NITROSYLATED HSA; PEO; PMMA; POLYETHYLENE OXIDE; POLYMETHYLMETHACRYLATE; SDS; SODIUM DODECYL SULFTATE; TBS; THP; TIC; TOTAL ION CURRENT; TRIS-BUFFERED SALINE;

CARBOXYPEPTIDASES A; ELECTROPHORESIS, CAPILLARY; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MASS SPECTROMETRY; OXIDATION-REDUCTION; SERUM ALBUMIN;

EID: 84885314982     PISSN: 00032670     EISSN: 18734324     Source Type: Journal    
DOI: 10.1016/j.aca.2013.09.023     Document Type: Article

References (33)

1. Boldt J. Br. J. Anaesth. 2010, 104:276-284.
2. Quinlan G.J., Martin G.S., Evans T.W. Hepatology 2005, 41:1211-1219.
3. Roche M., Rondeau P., Singh N.R., Tarnus E., Bourdon E. FEBS Lett. 2008, 582:1783-1787.
4. Colombo G., Clerici M., Giustarini D., Rossi R., Milzani A., Dalle-Donne I. Antioxid. Redox Sig. 2012, 17:1515-1527.
5. Bal W., Christodoulou J., Sadler P.J., Tucker A. J. Inorg. Biochem. 1998, 70:33-39.
6. Girard M., Bietlot H.P., Cyr T.D. J. Chromatogr. A 1997, 772:235-242.
7. Ogasawara Y., Namai T., Togawa T., Ishii K. Biochem. Biophys. Res. Commun. 2006, 340:353-358.
8. Medina-Navarro R., Durán-Reyes G., Díaz-Flores M., Vilar-Rojas C. PLoS ONE 2010, 5:1-11. http://www.plosone.org/.
9. Bar-Or D., Bar-Or R., Rael L.T., Gardner D.K., Slone D.S., Craun M.L. Crit. Care Med. 2005, 33:1638-1641.
10. Kawakami A., Kubota K., Yamada N., Tagami U., Takehana K., Sonaka I., Suzuki E., Hirayama K. FEBS J. 2006, 273:3346-3357.
11. Oettl K., Stauber R.E. Br. J. Pharmacol. 2007, 151:580-590.
12. Ishima Y., Hiroyama S., Kragh-Hansen U., Maruyama T., Sawa T., Akaike T., Kai T., Otagiri M. Nitric Oxide 2010, 23:121-127.
13. Turell L., Carballal S., Botti H., Radi R., Alvarez B. Braz. J. Med. Biol. Res. 2009, 42:305-311.
14. Rondeau P., Bourdon E. Biochimie 2011, 93:645-658.
15. Wa C., Cerny R.L., Clarke W.A., Hage D.S. Clin. Chim. Acta 2007, 385:48-60.
16. Ahmed N., Argirov O.K., Minhas H.S., Cordeiro C.A.A., Thornalley P.J. Biochem. J. 2002, 364:1-14.
17. Guerin-Dubourg A., Catan A., Bourdon E., Rondeau P. Diabetes Metab. 2012, 38:171-178.
18. Oettl K., Marsche G. Methods Enzymol. 2010, 474:181-195.
19. Taverna M., Marie A.-L., Mira J.-P., Guidet B. Ann. Intensive Care 2013, 3:1-7.
20. Dolnik V. Electrophoresis 2008, 29:143-156.
21. Denton K.A., Harris R. J. Chromatogr. A 1995, 705:335-341.
22. Alahmad Y., Tran N.T., Le Potier I., Forest E., Jorieux S., Taverna M. Electrophoresis 2011, 32:292-299.
23. Ramautar R., Heemskerk A.A.M., Hensbergen P.J., Deelder A.M., Busnel J.-M., Mayboroda O.A. J. Proteomics 2012, 75:3814-3828.
24. Haselberg R., de Jong G.J., Somsen G.W. J. Chromatogr. A 2007, 1159:81-109.
25. Haselberg R., de Jong G.J., Somsen G.W. Electrophoresis 2011, 32:66-82.
26. Shen Y., Smith R.D. J. Microcolumn Sep. 2000, 12:135-141.
27. Mokaddem M., Gareil P., Belgaied J.-E., Varenne A. Electrophoresis 2008, 29:1957-1964.
28. Mokaddem M., Gareil P., Belgaied J.-E., Varenne A. Electrophoresis 2009, 30:1692-1697.
29. Carballal S., Radi R., Kirk M.C., Barnes S., Freeman B.A., Alvarez B. Biochemistry 2003, 42:9906-9914.
30. Bar-Or D., Rael L.T., Bar-Or R., Slone D.S., Craun M.L. Clin. Chim. Acta 2006, 365:346-349.
31. Amundsen L.K., Sirén H. Electrophoresis 2007, 28:99-113.
32. Anraku M., Tsurusaki Y., Watanabe H., Maruyama T., Kragh-Hansen U., Otagiri M. Biochim. Biophys. Acta 2004, 1702:9-17.
33. Pavone B., Sirolli V., Bucci S., Libardi F., Felaco P., Amoroso L., Sacchetta P., Urbani A., Bonomini M. Blood Transfus. 2010, 8:113-119.